Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Revenue

Xilio Therapeutics had revenue of $12.65M in the quarter ending March 31, 2026, with 331.67% growth. This brings the company's revenue in the last twelve months to $53.48M, up 476.71% year-over-year. In the year 2025, Xilio Therapeutics had annual revenue of $43.77M with 589.88% growth.

• Revenue (ttm): $53.48M
• Revenue Growth: +476.71%
• P/S Ratio: 0.92
• Revenue / Employee: $703,737
• Employees: 76
• Market Cap: 49.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.77M	37.42M	589.88%
Dec 31, 2024	6.34M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 23, 2026

Data Sources Report a data error